LI JIANQI has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AHMED KAMAL, TES PHARMA S R L and CHENGDU DIAO PHARMACEUTICAL GROUP CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Li Jianqi | 13 |
#2 | Cai Wangping | 4 |
#3 | Gao Kai | 3 |
#4 | Lv Na | 3 |
#5 | Zhang Qingwei | 3 |
#6 | Wang Guan | 3 |
#7 | Zhang Guisen | 3 |
#8 | Zheng Yongyong | 3 |
#9 | Xie Peng | 2 |
#10 | Feng Juan | 1 |
Publication | Filing date | Title |
---|---|---|
US2014221431A1 | Histone deacetylase inhibitor of benzamides and use thereof | |
US2014235633A1 | 4-aminoquinazoline derivatives and uses thereof | |
US2011152323A1 | Histone deacetylase inhibitors and uses thereof | |
US2011160247A1 | Aralkyl alcohol pyridine derivative compounds and the use thereof as medicaments for treating depression | |
US2011160199A1 | Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia | |
US2011105503A1 | Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent | |
CN1385555A | Electrolytic pole board insulated covering edge and protective method |